Establishing the role of the human microbiome in patients with a presumed pancreatic or periampullary (pre)malignancy and pancreatic resection.
- Conditions
- microbiome10027656bacteria
- Registration Number
- NL-OMON56504
- Lead Sponsor
- Sint Antonius Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 200
- Adult patient with a resectable, borderline resectable or locally advanced
pancreatic and periampullary presumed (pre)malignancy.
- The intention of the treatment must be curative including surgery and
(neo-)adjuvant chemotherapy.
- Willing and able to adhere to the study procedures described in this protocol
and to grant the study team access to the electronic patient file and other
data that are required to answer the research questions described in this
protocol.
- Inability to provide adequate informed consent (e.g. language barrier,
illiteracy)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary objective of this study is to classify patients that undergo<br /><br>pancreatic resection into high and low risk groups for postoperative<br /><br>complications (see study protocol 8.3 for definitions), based on longitudinal<br /><br>saliva and/or rectal/faecal microbiome profiles.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary objectives include, but are not limited to, finding associations<br /><br>between saliva and/or rectal/faecal microbiome profiles and long term<br /><br>oncological outcomes (i.e. site of recurrence, disease free survival, overall<br /><br>survival), complications of neoadjuvant and/or adjuvant chemotherapy, response<br /><br>to neoadjuvant chemotherapy as judged by computed tomography (CT) scan and<br /><br>histological respons, complications associated with bile duct drainage and<br /><br>postoperative endo- and exocrine insufficiency. </p><br>